The presence and severity of NAFLD are associated with cognitive impairment and hippocampal damage.
暂无分享,去创建一个
Xuelin Ma | Xitai Sun | Y. Bi | Zhou Zhang | Wen Zhang | Sijue Yang | Congcong Yu | Bing Zhang | Linqing Fu | D. Fang | Yingwen Miao | Xiang Xu | Qun Ding | Tianyu Wu | Yinjiao Hou
[1] Anne B. Kim,et al. Insulin resistance, cognition, and Alzheimer disease , 2023, Obesity.
[2] G. Perseghin,et al. Diabetes mellitus is associated with higher serum neurofilament light chain levels in the general U.S. population. , 2022, The Journal of clinical endocrinology and metabolism.
[3] Luping Wang,et al. Risk of dementia or cognitive impairment in non-alcoholic fatty liver disease: A systematic review and meta-analysis , 2022, Frontiers in Aging Neuroscience.
[4] F. Underwood,et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. , 2022, The lancet. Gastroenterology & hepatology.
[5] Bing Zhang,et al. Enhancement of Impaired Olfactory Neural Activation and Cognitive Capacity by Liraglutide, but not Dapagliflozin or Acarbose, in Patients With Type 2 Diabetes: A 16-Week Randomized Parallel Comparative Study. , 2022, Diabetes care.
[6] J. Tardif,et al. Evaluation of Adiposity and Cognitive Function in Adults , 2022, JAMA network open.
[7] Y. Yılmaz,et al. Metabolic-associated Fatty Liver Disease (MAFLD): A Multi-systemic Disease Beyond the Liver. , 2021, Journal of clinical and translational hepatology.
[8] R. Simó,et al. Relationship between Central Obesity and the incidence of Cognitive Impairment and Dementia from Cohort Studies Involving 5,060,687 Participants , 2021, Neuroscience & Biobehavioral Reviews.
[9] V. Felipo,et al. A New Score Unveils a High Prevalence of Mild Cognitive Impairment in Patients with Nonalcoholic Fatty Liver Disease , 2021, Journal of clinical medicine.
[10] V. Wong,et al. Non-alcoholic fatty liver disease , 2021, The Lancet.
[11] K. Diers,et al. Insulin resistance accounts for metabolic syndrome‐related alterations in brain structure , 2021, Human brain mapping.
[12] K. Duncan,et al. Children’s family income is associated with cognitive function and volume of anterior not posterior hippocampus , 2020, Nature Communications.
[13] Naaheed Mukadam,et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission , 2020, The Lancet.
[14] S. Craft,et al. Brain insulin resistance in Alzheimer's disease and related disorders: mechanisms and therapeutic approaches , 2020, The Lancet Neurology.
[15] P. Vuilleumier,et al. Does inappropriate behavior hurt or stink? The interplay between neural representations of somatic experiences and moral decisions , 2020, Science Advances.
[16] S. Ikramuddin,et al. Nonalcoholic Steatohepatitis: A Review. , 2020, JAMA.
[17] P. Tariot,et al. Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease , 2019, JAMA neurology.
[18] S. Fargion,et al. Brain involvement in non-alcoholic fatty liver disease (NAFLD): A systematic review. , 2019, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[19] K. Cusi,et al. Modulation of Insulin Resistance in Nonalcoholic Fatty Liver Disease , 2019, Hepatology.
[20] Qing X. Yang,et al. Olfactory Dysfunction Mediates Adiposity in Cognitive Impairment of Type 2 Diabetes: Insights From Clinical and Functional Neuroimaging Studies , 2019, Diabetes Care.
[21] P. Tariot,et al. Randomized Trial of Verubecestat for Prodromal Alzheimer's Disease , 2019, The New England journal of medicine.
[22] P. Calabresi,et al. Neurofilament light chain as a biomarker in neurological disorders , 2019, Journal of Neurology, Neurosurgery, and Psychiatry.
[23] O. Franco,et al. C-Reactive Protein, Plasma Amyloid-&bgr; Levels, and Their Interaction With Magnetic Resonance Imaging Markers , 2018, Stroke.
[24] V. Gudnason,et al. Genetic overlap between vascular pathologies and Alzheimer's dementia and potential causal mechanisms , 2018, Alzheimer's & Dementia.
[25] Aad van der Lugt,et al. Subregional volumes of the hippocampus in relation to cognitive function and risk of dementia , 2018, NeuroImage.
[26] Qing X. Yang,et al. Altered Odor-Induced Brain Activity as an Early Manifestation of Cognitive Decline in Patients With Type 2 Diabetes , 2018, Diabetes.
[27] O. Markovic,et al. Cognitive Changes and Brain Volume Reduction in Patients with Nonalcoholic Fatty Liver Disease , 2018, Canadian journal of gastroenterology & hepatology.
[28] G. Marchesini,et al. Reactive hyperemia index (RHI) and cognitive performance indexes are associated with histologic markers of liver disease in subjects with non-alcoholic fatty liver disease (NAFLD): a case control study , 2018, Cardiovascular Diabetology.
[29] C. Byrne,et al. Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus , 2018, Nature Reviews Endocrinology.
[30] C. Cervellati,et al. Low-grade systemic inflammation is associated with functional disability in elderly people affected by dementia , 2018, GeroScience.
[31] D. Foguel,et al. Age-related cognitive impairment is associated with long-term neuroinflammation and oxidative stress in a mouse model of episodic systemic inflammation , 2018, Journal of Neuroinflammation.
[32] Steven E. Arnold,et al. Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums , 2018, Nature Reviews Neurology.
[33] E. Feldman,et al. Neurological consequences of obesity , 2017, The Lancet Neurology.
[34] C. Lewis,et al. Nonalcoholic Fatty Liver Disease and Measures of Early Brain Health in Middle Aged Adults: The CARDIA study , 2016, Obesity.
[35] S. Francque,et al. Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications. , 2016, Journal of hepatology.
[36] Jeanne M. Clark,et al. Nonalcoholic fatty liver disease is associated with cognitive function in adults , 2016, Neurology.
[37] E. Maguire,et al. Anterior hippocampus: the anatomy of perception, imagination and episodic memory , 2016, Nature Reviews Neuroscience.
[38] O. Garaschuk,et al. Neuroinflammation in Alzheimer's disease , 2015, The Lancet Neurology.
[39] K. Langa,et al. The diagnosis and management of mild cognitive impairment: a clinical review. , 2014, JAMA.
[40] S. Spencer,et al. Named Series : Diet , Inflammation and the Brain Obesity and neuroinflammation : A pathway to cognitive impairment , 2014 .
[41] V Shane Pankratz,et al. A prospective study of chronic obstructive pulmonary disease and the risk for mild cognitive impairment. , 2014, JAMA neurology.
[42] Chunbo Li,et al. Reliability and validity of the Repeatable Battery for the Assessment of Neuropsychological Status in community-dwelling elderly , 2011, Archives of medical science : AMS.
[43] B. Neuschwander‐Tetri,et al. Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings , 2011, Hepatology.
[44] O. Cummings,et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.
[45] J. Cummings,et al. The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment , 2005, Journal of the American Geriatrics Society.
[46] R. Karim,et al. NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome , 2002, Hepatology.
[47] R. Turner,et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.
[48] S. Folstein,et al. “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician , 1975 .
[49] R. Vasan,et al. Association of Nonalcoholic Fatty Liver Disease With Lower Brain Volume in Healthy Middle-aged Adults in the Framingham Study , 2018, JAMA neurology.
[50] S. Fargion,et al. Subclinical cerebrovascular disease in NAFLD without overt risk factors for atherosclerosis. , 2018, Atherosclerosis.
[51] Xiaoyu Sun,et al. Olfactory cortex degeneration in Alzheimer's disease and mild cognitive impairment. , 2015, Journal of Alzheimer's disease : JAD.